SHENZHEN, China, Dec. 19, 2022 /PRNewswire/ -- SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, today announced CE (Conformité Européenne) Mark approval for ...
Assures 100x upgraded detection sensitivity compare to ddPCR Higher the possibility of precision medicine in the 1st and 2nd stages of cancer patients SEOUL, South Korea--(BUSINESS WIRE)--GENECAST, ...
BEIJING, April 19, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in ...
Assay is based on the ADx-ARMS platform, and kits are assembled in AmoyDx’ manufacturing plant. Amoy Diagnostics has received market approval from China’s State Food and Drug Administration (SFDA) for ...
Validation of a novel diagnostic kit using the semi-dry dot-blot method for detecting metastatic lymph nodes in breast cancer. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I.
The addition of plasma next-generation sequencing to solid tissue biopsy improved detection of therapeutically targetable mutations in patients with stage IV non-small cell lung cancer, according to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results